Roche Tissue Diagnostics
Medical Research & Development
As an leader and innovator of tissue-based diagnostic solutions for patients worldwide, Roche Tissue Diagnostics (RTD), is leading the way in personalized healthcare, a term that refers to linking the most accurate diagnosis with the most targeted and relevant therapeutic available for each individual patient. Through excellence and innovation in science and engineering, the people of RTD are leading the discovery, development and delivery of diagnostic systems and biopsy-based cancer tests that are guiding the future of healthcare.
RTD provides more than 250 cancer tests with related instruments for delivery to over 90 countries, making the company the leading supplier of cancer diagnostic systems to the pathology market.